| Chief Technical Operations Officer (CTOO) of Haupt Pharma AG
Born in 1954. Dr. Brücher studied chemistry, pharmacy and human biology and was awarded a doctorate from the Centre for Hygiene and Medical Microbiology at the University of Marburg. From 1991 Dr. Brücher held various positions at SmithKline Beecham Pharma GmbH. He was appointed Managing Partner of Wülfing Pharma GmbH in 1996 and was Managing Director of Haupt Pharma Wülfing from Sept. 2008 til Jan. 2009. Dr. Brücher is member of the executive board effective February 1, 2009.
|
| Dietmar Rohleder
Chief Financial Officer (CFO) der Haupt Pharma AG
Born in Werdohl in 1966, trained and qualified as bank clerk with Deutsche Bank AG. From 1989 until 2004, Mr. Rohleder was employed at various locations and in various capacities in the Corporate Customer Credit Analysis and Business Customer Service departments of Deutsche Bank AG, most recently in Hagen. Since the beginning of 2005, he is a member of the management board of the company now operating under the name INVITA AG, in which position he is responsible for managing and controlling the affiliated company. Mr. Dietmar Rohleder has been appointed financial director of Haupt Pharma AG with effect from June 17, 2010. |
| Member of the extended executive board of Haupt Pharma AG and Managing Director of Haupt Pharma Berlin GmbH
Born in 1947, graduation as economist from the University of Bonn. After extensive experiences as Managing Director and CFO in companies such as Brau & Brunnen and Amoco Chemical as well as self-employed interim manager amongst others at Pitney Bowes Germany Mr Schwella became Managing Director of allegropharm GmbH in 2007. As a member of the extended executive board he retains responsibility for purchasing and IT.
|
